Effects of gliclazide, a new antidiabetic agent, on the platelet release reaction, role of adenylate cyclase.
D000244:Adenosine Diphosphate / Q000032:analysis; D000255:Adenosine Triphosphate / Q000032:analysis; D000262:Adenylyl Cyclases / Q000032:analysis; D001241:Aspirin / Q000494:pharmacology; D002250:Carbon Radioisotopes; D003094:Collagen / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism; D004176:Dipyridamole / Q000494:pharmacology; D005907:Gliclazide / Q000494:pharmacology*; D005966:Glucuronidase / Q000032:analysis; D006801:Humans; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism; D010973:Platelet Adhesiveness / Q000187:drug effects*; D011458:Prostaglandins E / Q000494:pharmacology; D012701:Serotonin / Q000032:analysis; D013453:Sulfonylurea Compounds / Q000494:pharmacology*; D013917:Thrombin / Q000494:pharmacology; D014316:Tritium
D002250:Carbon Radioisotopes; D011458:Prostaglandins E; D013453:Sulfonylurea Compounds; D014316:Tritium; D012701:Serotonin; D000244:Adenosine Diphosphate; D004176:Dipyridamole; D000255:Adenosine Triphosphate; D003094:Collagen; D000242:Cyclic AMP; D010727:Phosphoric Diester Hydrolases; D005966:Glucuronidase; D013917:Thrombin; D000262:Adenylyl Cyclases; D005907:Gliclazide; D001241:Aspirin